Printed from Voxsanity (voxsanity.com.au) — NCT06786312 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Lung Cancer
Phase 2 Lung Cancer Trial, Not Yet Recruiting
NCT06786312
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People diagnosed with extensive stage small cell lung cancer (a type of lung cancer that has spread widely), confirmed by a tissue or cell sample — but not a mixed or combined type of small cell lung cancer.
- People aged 18 to 75 years old (inclusive) at the time of signing the consent form, either male or female.
- People with a general health and activity level rated as 0 or 1 on a standard oncology scale, meaning they are fully active or have only minor restrictions on physical activity (confirm with trial site).
- People who have not yet received any systemic treatment for their extensive stage small cell lung cancer.
- People who have at least one area of cancer that can be measured on a scan, meeting specific size criteria used in cancer trials (confirm with trial site).
- People whose doctors expect them to live for at least 3 months or more.
- People whose major organs — including blood, liver, kidneys, and heart — are functioning within acceptable ranges based on blood tests and an ultrasound of the heart (confirm with trial site for specific values).
- People with brain metastases (cancer that has spread to the brain) that are not causing symptoms, or that have been treated and are stable, and where steroid and anti-seizure medications have been stopped for at least 1 month before starting the trial.
- Women of reproductive age who agree to use contraception during the study and for 6 months after it ends, have a negative pregnancy blood test within 28 days before joining, and are not breastfeeding; and men who agree to use contraception during the study and for 6 months after it ends.
- People who voluntarily agree to join the study, sign a consent form, are willing to follow the study requirements, and are able to attend follow-up appointments.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are known to be allergic to any of the medications used in the trial.
- People who have had, or currently have, another type of cancer — unless it was certain low-risk or early-stage cancers (such as a specific type of skin cancer, early cervical cancer, early breast cancer, or early thyroid cancer), or another cancer that was fully treated and cured at least 5 years ago with no signs of return or spread.
- People who have brain or spinal fluid metastases that are currently causing symptoms, or that are considered active and not yet treated or stabilised.
- People with an active autoimmune disease or immune deficiency condition, or a history of one.
- People who experienced significant bleeding — such as coughing up blood, vomiting blood, or gastrointestinal bleeding — within 3 months before starting the trial.
- People whose scans show that the cancer has grown into major blood vessels, or where the boundary between the cancer and major blood vessels is unclear, or where the treating doctor believes there is a high risk of the cancer causing life-threatening bleeding during treatment.
- People with high blood pressure that remains uncontrolled despite medication (with specific readings above set thresholds — confirm with trial site).
- People who have had a serious heart or brain blood vessel event in the 6 months before starting the trial — such as a stroke (excluding minor types), heart attack, unstable chest pain, or a poorly controlled irregular heartbeat — or who have significant heart failure or reduced heart pumping function (confirm with trial site for specific thresholds).
- People with an active or uncontrolled serious infection, known HIV infection, active hepatitis B virus infection (based on specific blood test levels), hepatitis C virus infection (based on specific blood test levels), or other forms of hepatitis or liver cirrhosis.
- People with uncontrolled fluid build-up in the chest, around the heart, or in the abdomen that the treating doctor believes requires draining, or who had fluid drained from these areas within 14 days before starting the trial.
- People with current or previous lung inflammation or scarring conditions (such as interstitial lung disease, pulmonary fibrosis, or radiation- or drug-related pneumonia), or any signs of active lung inflammation on a chest scan, or severely reduced lung function confirmed by current testing.
- People who needed corticosteroid tablets or injections above a low threshold dose, or other immune-suppressing medications, within 14 days before starting the trial or during the study — with some exceptions for low-dose or inhaled steroids (confirm with trial site).
- People who have a condition that affects how medications are absorbed by the body, or who are unable to swallow oral tablets.
- People whose urine tests show a high level of protein, confirmed by a 24-hour urine collection test above a specified amount (confirm with trial site).
- People whom the treating doctor considers unsuitable for the trial for any other clinical or health-related reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Contact this trial
Phone: +86 13706990793
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Fujian Cancer Hospital
Registry
ClinicalTrials.gov
Start date
25 January 2025
Est. completion
25 July 2027
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Progression free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.